p130Cas mediates the transforming properties of the anaplastic lymphoma kinase.

Titlep130Cas mediates the transforming properties of the anaplastic lymphoma kinase.
Publication TypeJournal Article
Year of Publication2005
AuthorsAmbrogio C, Voena C, Manazza AD, Piva R, Riera L, Barberis L, Costa C, Tarone G, Defilippi P, Hirsch E, Erba EBoeri, Mohammed S, Jensen ON, Palestro G, Inghirami G, Chiarle R
JournalBlood
Volume106
Issue12
Pagination3907-16
Date Published2005 Dec 01
ISSN0006-4971
KeywordsAnaplastic Lymphoma Kinase, Animals, Cell Line, Cell Movement, Cell Transformation, Neoplastic, Crk-Associated Substrate Protein, Cytoskeleton, Electrophoresis, Polyacrylamide Gel, Humans, Immunoblotting, Immunoprecipitation, Lymphoma, Large B-Cell, Diffuse, Mass Spectrometry, Mice, Oncogene Proteins, Fusion, Phosphorylation, Protein-Tyrosine Kinases, Receptor Protein-Tyrosine Kinases, Tumor Cells, Cultured
Abstract

Translocations of the anaplastic lymphoma kinase (ALK) gene have been described in anaplastic large-cell lymphomas (ALCLs) and in stromal tumors. The most frequent translocation, t(2;5), generates the fusion protein nucleophosmin (NPM)-ALK with intrinsic tyrosine kinase activity. Along with transformation, NPM-ALK induces morphologic changes in fibroblasts and lymphoid cells, suggesting a direct role of ALK in cell shaping. In this study, we used a mass-spectrometry-based proteomic approach to search for proteins involved in cytoskeleton remodeling and identified p130Cas (p130 Crk-associated substrate) as a novel interactor of NPM-ALK. In 293 cells and in fibroblasts as well as in human ALK-positive lymphoma cell lines, NPM-ALK was able to bind p130Cas and to induce its phosphorylation. Both of the effects were dependent on ALK kinase activity and on the adaptor protein growth factor receptor-bound protein 2 (Grb2), since no binding or phosphorylation was found with the kinase-dead mutant NPM-ALK(K210R) or in the presence of a Grb2 dominant-negative protein. Phosphorylation of p130Cas by NPM-ALK was partially independent from Src (tyrosine kinase pp60c-src) kinase activity, as it was still detectable in Syf-/- cells. Finally, p130Cas-/- (also known as Bcar1-/-) fibroblasts expressing NPM-ALK showed impaired actin filament depolymerization and were no longer transformed compared with wild-type cells, indicating an essential role of p130Cas activation in ALK-mediated transformation.

DOI10.1182/blood-2005-03-1204
Alternate JournalBlood
PubMed ID16105984
PubMed Central IDPMC1895100
Grant ListR01-CA64033 / CA / NCI NIH HHS / United States
Related Faculty: 
Giorgio Inghirami, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700